Search GCTK
Glucotrack, Inc.
Nasdaq · CIK 1506983
Last close1.21
Daily change-0.20 (-14.18%)
10 Years gain-100.00%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
GCTK · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
20.2Momentum
n/aAcceleration
n/aConfidence
63.0Annual Revenue6
Quarterly Revenue21
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality3.8 / 25
Capital Efficiency0.4 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM-50.08%OK
Revenue CAGR 3Y-30.2%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $0.00 | -$16.09M | -$15.24M | -$15.34M | n/a | n/a | n/a | n/a | 621,094 |
| 2025 FY Dec 31, 2024 | n/a | $0.00 | -$14.55M | -$12.49M | -$12.59M | n/a | n/a | n/a | n/a | 5,503 |
| 2024 FY Dec 31, 2023 | n/a | $0.00 | -$7.10M | -$6.56M | n/a | n/a | n/a | n/a | n/a | 207,603 |
| 2023 FY Dec 31, 2022 | n/a | $0.00 | -$4.43M | -$3.73M | -$3.73M | n/a | n/a | n/a | n/a | 15.47M |
| 2022 FY Dec 31, 2021 | n/a | $0.00 | -$4.04M | -$3.77M | -$3.77M | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $70,016.00 | sum latest 4 fiscal quarters Revenue | OK | 0001493152-21-008654, 0001493152-20-009415 |
| Revenue Growth TTM | -50.08% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-21-008654, 0001493152-20-009415 |
| Revenue CAGR 3Y | -30.2% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-21-008654 |
| Revenue CAGR 5Y | 28.32% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-21-008654 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001493152-21-008654 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 8.43x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001493152-21-008654 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001493152-21-008654 |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |
| Gross Margin Delta 3Y | n/a | GrossMargin_current - GrossMargin_3Y_ago | INSUFFICIENT_HISTORY | derived |